Atlas Trials

Squamous Cell Non-Small Cell Lung Cancer

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Squamous Cell Non-Small Cell Lung Cancer

RecordFirmDate
HLX35(EGFR×4-1BB Bispecific) in Patients With Advanced or Metastatic Solid Tumors (NCT05360381)Shanghai Henlius Biotech2022-06-03
A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201) (NCT05267470)Amgen2022-03-29
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors (NCT04977453)GI Innovation, Inc.2021-08-02
SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer (NCT04171284)Sinocelltech Ltd.2019-10-22
Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC) (NCT03762122)Swiss Cancer Institute2019-07-25
MGD019 DART® Protein in Unresectable/Metastatic Cancer (NCT03761017)MacroGenics2018-12-12
A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer (NCT02283320)BIND Therapeutics2014-09-01
Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens (NCT01721759)Bristol-Myers Squibb2012-11-16
Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017) (NCT01642004)Bristol-Myers Squibb2012-10-16

Track Squamous Cell Non-Small Cell Lung Cancer automatically

Every clearance here is in the API, with alerts when new ones post.